Document is current
Any future updates will be listed below
-
Authors
Filipenko, Dina https://orcid.org/0000-0002-4398-4367
Acquadro, Michael
Ghatnekar, Ola
Samuelsen, Carl Haakon
Griebsch, Ingolf
-
Funding
Funding for this research was provided by:
Ferring
- License Information
-
More Information
Article History
Received: 11 November 2025
Accepted: 6 February 2026
First Online: 4 March 2026
Declarations
:
: Dina Filipenko is an employee of PPD Evidera Patient-Centered Research, Thermo Fisher Scientific, which received funds from Ferring Pharmaceuticals to conduct the study. Michael Acquadro was an employee of PPD Evidera Patient-Centered Research, Thermo Fisher Scientific, at the time of the study. Ingolf Griebsch, Ola Ghatnekar, and Carl Haakon Samuelsen were employees of Ferring Pharmaceuticals at the time of the study. Ola Ghatnekar is currently an employee of Societal Evidence AB. Carl Haakon Samuelsen is currently an employee of Outcomes Analytica.
: The study protocol was approved by an institutional review board (Salus IRB Board IRB00013544) before initiation of interviews. Prior to their interviews, all study participants provided their informed consent to report and disseminate their anonymized data. Participants were remunerated upon completion of the interviews.
